Navigation Links
WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility

SHANGHAI, Feb. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.

(Logo: )

AAALAC is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. It evaluates all aspects of an animal care and use program, including institutional policies, animal husbandry, veterinary care and the physical plant. In its evaluations, it relies on widely accepted guidelines, such as the Guide for the Care and Use of Laboratory Animals and other reference resources, as well as its own position statements and Rules of Accreditation.

"AAALAC accreditation establishes that our Suzhou facility meets international standards of animal care," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "This accreditation continues to demonstrate WuXi's ability to provide our global customers with high quality service in a regulatory compliant environment. We believe that China will become a major market for non-clinical safety testing services over the next decade, and our company aims to become a leading provider of such services in China. At 314,000 square feet and 108 animal rooms, our Suzhou facility is the largest in China.

"We have built world-class facilities not just in Suzhou but throughout our organization," Dr. Li continued. "Developing this new toxicology service capability further broadens our integrated service platform across drug discovery and preclinical development. Our mission is to help our customers to improve the success of discovery and shorten the time of development."

    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-201-585-2048

     Stephanie Liu
     Associate Director of Corporate Communications Department
     Tel:   +86-21-5046-4362


SOURCE WuXi PharmaTech (Cayman) Inc.

Back to top



SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
2. WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award
3. WuXi PharmaTech Announces Third Quarter 2007 Results
4. WestChina-Frontier PharmaTech Awarded Full AAALAC Accreditation
5. WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
6. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
7. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
8. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
9. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
10. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
11. WuXi PharmaTech 2007 Annual Report Available Online
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... Stress, anxiety, illness, ... a parent worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon ... are common, some signs might point to tumors. , “Bad headaches that ...
(Date:11/30/2015)... Minneapolis, MN (PRWEB) , ... November 30, 2015 ... ... launched at . The directory is specialized and only includes chiropractic ... is to find a competent and trustworthy alternative health practitioner when back pain ...
(Date:11/30/2015)... ... , ... The world of hair transplants and restoration is filled with methods ... procedures have been in use for many years and are among the most commonly ... has utilized many of these methods over the years, he also keeps an eye ...
(Date:11/30/2015)... ... 2015 , ... In an effort to make it easier ... information provided directly from top experts in mesothelioma, in 2016 the International ... major cities: Houston, San Francisco, and Chicago. , “For many mesothelioma patients ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to an ... made a brave but slightly unusual choice to show her Instagram followers that the ... form may have been pre-mature. Saying that she didn’t “want to mislead any mommy's ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... TERRACE, Wash. and ST. LOUIS ... and Express Scripts (NASDAQ: ESRX ) today announced ... agreement. The partnership, which began in 1999, will now ... --> --> After evaluating pharmacy benefit ... Premera concluded that Express Scripts continues to offer the ...
(Date:11/30/2015)... NASHUA, N.H. , Nov. 30, 2015 /PRNewswire/ ... today that it will feature its latest solutions ... the early identification of cancer at the Radiological ... in Chicago from November ... showcase recent product advances including iReveal®, an automated ...
(Date:11/30/2015)... , Nov. 30, 2015 NHS ... further 20 TrueBeam™ machines from Varian Medical Systems ... ongoing program to replace older machines and institute ... the UK,s public hospitals. The order, placed in ... 50 licenses for Varian,s RapidArc® and Eclipse™ software ...
Breaking Medicine Technology: